The Investment is part of BrainsWay’s ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative careBURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has entered into a strategic equity financing agreement w ...

Financial Data and Key Metrics Changes - Revenue grew 11% year over year to $345 million, driven by better-than-expected clinician productivity and total revenue per visit [13] - Adjusted EBITDA increased 19% year over year to $34 million, with adjusted EBITDA margin at 9.8% [15] - Free cash flow reached $57 million, the highest in the company's history, with a solid cash position of $189 million [16] Business Line Data and Key Metrics Changes - The clinician base increased by 173 clinicians this quarter, totaling 7,780 clinicians, an 11% year-over-year increase [14] - Visit volumes rose 12% year over year to 2.2 million, primarily driven by clinician growth [13] Market Data and Key Metrics Changes - The company expects to achieve mid-teens revenue growth in 2026, supported by increasing demand for mental health services [12] - The company anticipates a low to mid single-digit rate improvement and continued organic growth of the clinician base [12] Company Strategy and Development Direction - The company is focused on expanding access to high-quality and affordable mental healthcare, leveraging both in-person and virtual care [6] - Investments in technology, including AI and digital solutions, are aimed at improving operational efficiency and clinician satisfaction [10][11] - The company is exploring M&A opportunities for geographic expansion, particularly in new markets [76] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating a dynamic healthcare environment and achieving double-digit margins for the full year [6][18] - The company is optimistic about the future, expecting to benefit from industry tailwinds and increasing demand for mental health services [20] Other Important Information - The company has implemented a patient engagement platform to improve acquisition and retention [8] - A new Chief Technology Officer has been appointed to lead digital transformation initiatives [11] Q&A Session Summary Question: Confidence level for Q4 ramp and productivity improvements - Management expressed strong confidence in revenue growth for the second half of the year, expecting approximately $60 million of revenue growth driven by visit volume and rate increases [26] Question: Clinician adds and retention dynamics - Management noted stable retention and strong recruiting, validating the company's value proposition in a competitive environment [30] Question: Updates on managed care contracting and cash pay shift - Management highlighted a trend of patients shifting from cash pay to insurance, which is expected to benefit the company [34] Question: Sustainability of volume growth and productivity initiatives - Management detailed that productivity initiatives are expected to contribute significantly to volume growth, with a focus on filling clinician schedules [41] Question: Free cash flow outlook - Management indicated that while Q3 cash flow may decrease due to various factors, the overall trajectory for free cash flow remains positive [48] Question: Impact of AI tools and EHR initiative - Management stated that AI tools are being implemented to improve efficiency and clinician experience, with ongoing evaluation of EHR solutions [98]

Financial Performance - Q2 2025 revenue reached $345.3 million, an 11% year-over-year increase[9] - Q2 2025 Center Margin was $108.4 million, representing 31.4% of revenue[9] - Q2 2025 Adjusted EBITDA was $34.0 million, or 9.8% of revenue[9] - The company ended Q2 2025 with a cash position of $188.9 million[9] - Full year 2025 revenue guidance is reaffirmed at $1.40 billion - $1.44 billion[19] - Full year 2025 Adjusted EBITDA guidance is raised to $140 million - $150 million[19] Operational Metrics - Total clinicians reached 7,708, an 11% year-over-year growth, with 173 net clinician additions in Q2[9, 8] - Q2 2025 visit volumes increased by 12% year-over-year to 2.2 million[9] - The company operates over 550 centers in 33 states[8] Balance Sheet and Capital Allocation - Cash and cash equivalents totaled $189 million[17] - Net long-term debt is $273 million[17]

Financial Data and Key Metrics Changes - Total revenue for the second quarter was $38.1 million, an 18% year-over-year increase on an adjusted pro forma basis [7][25] - Revenue from the NeuroStar business was $15.1 million, with U.S. treatment session revenue increasing by 13% on a pro forma basis [7][27] - Gross margin decreased to 46.6% compared to 74% in the prior year quarter, primarily due to the inclusion of Green Brook's lower-margin clinic business [28] - Net loss for the quarter was $9.8 million, or $0.15 per share, compared to a net loss of $9.8 million, or $0.33 per share, in the prior year quarter [29] Business Line Data and Key Metrics Changes - NeuroStar system revenue was $3.5 million with 41 systems shipped, demonstrating a strong average selling price [27] - U.S. clinic revenue reached $23 million, marking the strongest quarterly performance for Green Brook [28] - The Better Me Provider (BMP) program has 395 active sites, treating three times more patients per site compared to non-BMP practices [13][14] Market Data and Key Metrics Changes - The company has seen a 25% growth in adolescent new patient starts in 2025 compared to 2024, driven by increased insurance coverage [20] - The publication of clinical data in a reputable journal highlighted the effectiveness of the NeuroStar TMS system in adolescents, with nearly 70% experiencing clinically meaningful improvement [21] Company Strategy and Development Direction - The company is focusing on three strategic priorities: executing the Green Brook growth strategy, scaling the BMP program, and improving operational efficiencies [8][9] - The Green Brook growth strategy has exceeded expectations, with improved patient conversion rates through enhanced patient connection capabilities [10] - The company is taking a thoughtful approach to expanding the buy and bill model for SPRAVATO, focusing on opportunities that deliver good margins [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving cash flow positivity by the end of 2025, supported by operational improvements and strategic initiatives [35] - The integration of Neuronetics and Green Brook is creating significant value, positioning the company for sustainable growth and profitability [36] Other Important Information - Cash used in operations for the second quarter was $3.5 million, better than the previously guided target of under $5 million [31] - The company has received additional funding under its existing debt agreement, enhancing financial flexibility [30] Q&A Session Summary Question: Dynamics of traditional NeuroStar business vs. Green Brook - Management indicated that the shift in strategy towards provider connections is expected to improve conversion rates over time, despite a slower growth in traditional NeuroStar business [40][42] Question: Impact of marketing strategy on long-term spending - The new strategy is anticipated to make marketing dollars more efficient, potentially lowering overall marketing spend while still requiring some investment in educational efforts [43][44] Question: Resubmitted claims and reimbursement timing - Management is focused on improving revenue cycle management and expects to see a tailwind from catching up on aged claims while enhancing the efficiency of new claims [46][48] Question: Clinical sales per site and long-term expectations - Management did not provide a specific target for clinical sales per site but indicated that revenue trends and site performance would continue to improve [53][55] Question: Marketing strategy for adolescent patients - The company is targeting providers who care for adolescent patients through the Provider Connection program, which has shown positive results in driving awareness and adoption [59]

Company Overview - Neuronetics and Greenbrook have combined to leverage scale and capabilities for mental health treatment[17] - The combined company has treated 221,376 unique patients[18] and administered 7,912,427 treatments[19] - The company reported $129 million in annual revenue for 2024 (pro forma adjusted)[19] Market and Opportunity - The total available market is 293 million U S adults and adolescents suffering from depression, depression with anxiety, and OCD[33,34] - Approximately 8 million patients are poorly served by antidepressant medication[34] - Better Me Program (BMP) clinics treat 33 times more patients than non-BMP clinics[57,58] Financial Performance and Guidance - Q2 2025 revenue was $381 million, a 132% increase from Q2 2024[90] - The company projects revenue between $149 million and $155 million for FY 2025, representing a 15% to 19% pro forma year-over-year growth[85] - The company anticipates achieving positive cash flow from operations in Q4 2025[85]

Financial Performance - Second Quarter 2025 revenue reached $64 million[6] - Payor revenue increased by 35% year-over-year[16] - Adjusted EBITDA grew nearly 100% year-over-year[16] - The company has approximately $103 million in cash and equivalents, including available for sale securities, with zero debt[16] - Approximately $14 million of shares were repurchased under the company's buyback plan[16] Business Growth & Innovation - Unique Active Payor Members increased by 25%, and Payor sessions grew by 29% year-over-year[15] - The company is partnering with AWS Generative AI Innovation Center to develop a Safety and Quality Model[15] - The company enhanced its suicide detection technology and expanded into areas like substance misuse and abuse or neglect[15] Partnerships & Expansion - The company deepened its relationship with Amazon by launching Amazon Pharmacy Integration[16] - The company expanded in women's health through a new partnership with Tia Health[16] - Several additional partners, such as Genomind, Bark, and Hinge, will integrate Talkspace into their ecosystem[16] Financial Guidance - The company maintains its revenue guidance of $220 million to $235 million, representing a 17% to 25% year-over-year increase[21] - The company maintains its Adjusted EBITDA guidance of $14 million to $20 million, representing a 101% to 187% year-over-year increase[22]

Core Insights - Maple Tree Counselling is a rapidly growing multicultural therapy center in Central, Hong Kong, redefining mental health support in the region [1][11] - The practice offers a wide range of services including individual therapy, couples therapy, family conflict resolution, and corporate wellness programs [1][4][6] Service Offerings - Services include one-on-one counselling, trauma therapy, couples work, family conflict resolution, and corporate wellness programs [1][4] - The practice provides individual therapy for adults and adolescents dealing with various issues such as anxiety, depression, and trauma [5] - Group therapy sessions and corporate mental health solutions like on-site counselling are also available [5][7] Team and Expertise - The team consists of internationally trained therapists fluent in English, Cantonese, and Mandarin, catering to both local and global communities [3][8] - Specializations include Cognitive Behavioural Therapy (CBT), Eye Movement Desensitization and Reprocessing (EMDR), and mindfulness-based interventions [9] Corporate Engagement - Maple Tree Counselling has seen increased demand from the business sector, collaborating with HR departments to implement mental health programs [6] - Offerings for corporate clients include mental health check-ins, custom workshops, and on-site counselling services [7] Leadership and Growth - Anjali Nihalchand, Co-founder and Director, emphasizes the importance of a non-judgmental third party in couples therapy [5] - The practice is expanding its team with new specialists, such as Julia Laubscher, who focuses on couples counselling [10] Industry Impact - Maple Tree Counselling is at the forefront of evolving mental health conversations in Asia, working to remove stigma and promote self-awareness [11]

Group 1 - Talkspace is the largest in-network provider of virtual mental health services in the US, covering almost 200 million lives through major health insurers, employers, and EAP partnerships [1] - Users on the Talkspace platform can access therapy through real-time video [1]

Core Points - Magellan Health, Inc. has launched a complimentary 24-hour crisis line to support individuals affected by flash flooding in New Mexico [1] - The crisis line offers free, confidential consultation services to help individuals cope with feelings of fear, sadness, anger, or hopelessness due to natural disasters [2] - Additional resources for trauma recovery and emergency preparedness are available on Magellan Health's website and Ready.gov [3][4] Company Initiatives - The crisis line is part of Magellan Health's commitment to provide mental health and substance use solutions during community crises [4] - The company aims to assist local communities in responding, reacting, and rebuilding after traumatic events [4] Available Resources - Tip sheets and resources specific to trauma recovery can be accessed on Magellan Health's website [3] - Support materials for coping with grief and assisting employees during traumatic events are available in both English and Spanish [5]

Core Insights - The report indicates that 60% of consumers prioritize emotional consumption, with 90% willing to pay a premium for emotional value, projecting the emotional consumption market in China to exceed 2 trillion yuan by 2025 [1] - Heilongjiang is experiencing a surge in "emotional economy," reflecting a trend of consumption upgrade [1] Group 1: Emotional Consumption Trends - The emotional consumption market is characterized by a shift from traditional consumption to a focus on emotional value and psychological satisfaction [20] - The pet café in Harbin, featuring a snow fox named "Doubao," exemplifies how unique experiences can attract consumers seeking emotional comfort [2][5] - The urban landscape of Harbin offers diverse emotional experiences, catering to different age groups and their emotional needs [6] Group 2: Market Growth and Statistics - The urban pet market in China is projected to surpass 300 billion yuan in 2024, with a year-on-year growth of approximately 7.5% [5] - The cultural tourism IP market in China is expected to reach 431.4 billion yuan in 2024, reflecting a year-on-year increase of 15.5% [5] - The number of emotional and mental health-related enterprises in Heilongjiang has seen a significant increase, with a 220% year-on-year growth in registrations since 2024 [20] Group 3: Consumer Behavior and Preferences - Consumers are increasingly seeking emotional outlets, with many visiting emotional support establishments to cope with stress and anxiety [15][17] - The rise of emotional consumption is evident across various demographics, with older consumers also engaging in experiences that provide emotional healing [6][21] - Unique retail environments that emphasize aesthetic design and emotional resonance are driving consumer spending in the emotional consumption sector [14]